The new software was also added to the FDA's Tap Pilot program, an honor reserved for “high-quality, safe, effective and innovative medical devices."

Researchers say their new analysis, based on five years of U.S. data, highlights just how important it is to keep post-TAVR PPMI rates to a minimum. 

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift. 

Data from nearly 9.9 million participants were included in the team’s final analysis. The group emphasized the important role governments can play in trying to reverse the world's reliance on these products. 

The 57-year-old father of two is still in good health decades after receiving a new heart. 

“It can be a challenging discussion to have with patients because there is evidence that cannabis has some therapeutic properties," one researcher said. "However, as suggested by this study, cannabis use also has significant cardiovascular risks.”  

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

CT calcium scoring provides valuable evaluations of intermediate-risk patients in addition to making good business sense for hospitals. Nauman Mushtaq, MD, an interventional cardiologist with Northwestern, shared his own experience with this technology.